FGFR1-activated Translation of WNT Pathway Components with Structured 5' UTRs is Vulnerable to Inhibition of EIF4A-dependent Translation Initiation

Cooperativity between WNT and FGF signaling is well documented in embryonic development and cancer progression, but the molecular mechanisms underlying this cross-talk remain elusive. In this study, we interrogated the dynamics of RNA levels, ribosome occupancy, and protein expression as a function of inducible FGF signaling in mouse mammary glands with constitutive WNT hyperactivation. Multiomics correlation analysis revealed a substantial discrepancy between RNA and ribosome occupancy levels versus protein levels. However, this discrepancy decreased as cells became premalignant and dynamically responded to FGF signaling, implicating the importance of stringent gene regulation in nontransformed cells. Analysis of individual genes demonstrated that acute FGF hyperactivation increased translation of many stem cell self-renewal regulators, including WNT signaling components, and decreased translation of genes regulating cellular senescence. WNT pathway components translationally upregulated by FGF signaling had long and structured 5' UTRs with a high frequency of polypurine sequences, several of which harbored (CGG)4 motifs that can fold into either stable G-quadruplexes or other stable secondary structures. The FGF-mediated increase in translation of WNT pathway components was compromised by silvestrol, an inhibitor of EIF4A that clamps EIF4A to polypurine sequences to block 43S scanning and inhibits its RNA-unwinding activity important for translation initiation. Moreover, silvestrol treatment significantly delayed FGF-WNT-driven tumorigenesis. Taken together, these results suggest that FGF signaling selectively enhances translation of structured mRNAs, particularly WNT signaling components, and highlight their vulnerability to inhibitors that target the RNA helicase EIF4A.Significance: The RNA helicase EIF4A may serve as a therapeutic target for breast cancers that require FGF and WNT signaling. Cancer Res; 78(15); 4229-40. ©2018 AACR.

[1]  J. A. Waldron,et al.  eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes , 2018, Nucleic acids research.

[2]  Tao Liu,et al.  Genome-wide identification and differential analysis of translational initiation , 2017, Nature Communications.

[3]  Maxime W. C. Rousseaux,et al.  An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant Pathways * , 2017, Molecular & Cellular Proteomics.

[4]  Wenjun Guo,et al.  Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation. , 2016, Cell reports.

[5]  Nicholas T. Ingolia,et al.  Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor , 2016, Nature.

[6]  D. Edwards,et al.  Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation , 2016, Nature Cell Biology.

[7]  Xuerui Yang,et al.  Genome-wide assessment of differential translations with ribosome profiling data , 2016, Nature Communications.

[8]  D. Edwards,et al.  Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer , 2015, Breast Cancer Research.

[9]  A. Rosenwald,et al.  A Phase I Pharmacologic Study of Necitumumab (imc-11f8), a Fully Human Igg1 Monoclonal Antibody Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High Myc Levels in Colorectal Cancer , 2022 .

[10]  P. Tan,et al.  Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer , 2015, Breast Cancer Research and Treatment.

[11]  Maxwell R. Mumbach,et al.  Dynamic profiling of the protein life cycle in response to pathogens , 2015, Science.

[12]  Alexis Battle,et al.  Impact of regulatory variation from RNA to protein , 2015, Science.

[13]  Jeffrey M. Rosen,et al.  Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium , 2015, The Journal of cell biology.

[14]  E Provenzano,et al.  The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape , 2015, Cell Death and Disease.

[15]  Konstantinos J. Mavrakis,et al.  RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer , 2014, Nature.

[16]  M. Grever,et al.  The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease , 2014, Oncotarget.

[17]  Yvonne J. Goos,et al.  Translation of branched-chain aminotransferase-1 transcripts is impaired in cells haploinsufficient for ribosomal protein genes. , 2014, Experimental hematology.

[18]  Charity W. Law,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[19]  A. Oudenaarden,et al.  Feedback Control of Gene Expression Variability in the Caenorhabditis elegans Wnt Pathway , 2013, Cell.

[20]  Elgene Lim,et al.  Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. , 2013, Cancer cell.

[21]  G. Landberg,et al.  Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells , 2013, PloS one.

[22]  T. Griffin,et al.  Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner , 2012, PloS one.

[23]  Anna M. McGeachy,et al.  The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments , 2012, Nature Protocols.

[24]  M. Grever,et al.  Dual Targeting of the Cyclin/Rb/E2F and Mitochondrial Pathways in Mantle Cell Lymphoma with the Translation Inhibitor Silvestrol , 2012, Clinical Cancer Research.

[25]  Jill P. Mesirov,et al.  MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.

[26]  P. Stadler,et al.  ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology : AMB.

[27]  Christine Vogel,et al.  Protein Expression Regulation under Oxidative Stress* , 2011, Molecular & Cellular Proteomics.

[28]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[29]  Stephen Neidle,et al.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? , 2011, Nature Reviews Drug Discovery.

[30]  E. Lander,et al.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling , 2010, Proceedings of the National Academy of Sciences.

[31]  Jason I. Herschkowitz,et al.  Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. , 2010, Cancer research.

[32]  David H. Mathews,et al.  RNAstructure: software for RNA secondary structure prediction and analysis , 2010, BMC Bioinformatics.

[33]  A. Ashworth,et al.  FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. , 2010, Cancer research.

[34]  Mei Zhang,et al.  Selective targeting of radiation-resistant tumor-initiating cells , 2010, Proceedings of the National Academy of Sciences.

[35]  R. Cencic,et al.  Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol , 2009, PloS one.

[36]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[37]  A. Aman,et al.  Wnt/beta-catenin and Fgf signaling control collective cell migration by restricting chemokine receptor expression. , 2008, Developmental cell.

[38]  Eran Segal,et al.  Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.

[39]  S. Hyberts,et al.  PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains , 2008, Proceedings of the National Academy of Sciences.

[40]  Jos Jonkers,et al.  MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer , 2007, Nature Genetics.

[41]  Michele Pagano,et al.  S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.

[42]  Jeffrey M. Rosen,et al.  Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model , 2005, The Journal of cell biology.

[43]  D. Ambrosetti,et al.  Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation , 2005, The Journal of cell biology.

[44]  B. Welm,et al.  Inducible dimerization of FGFR1 , 2002, The Journal of cell biology.

[45]  Tohru Itoh,et al.  WNT Signals Control FGF-Dependent Limb Initiation and AER Induction in the Chick Embryo , 2001, Cell.

[46]  N. Sonenberg,et al.  The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure. , 2001, RNA.

[47]  M. Hung,et al.  β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .

[48]  Shannon R. Magari,et al.  Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Koopmeiners,et al.  Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation. , 2014, Cancer research.

[50]  Michele Pagano,et al.  S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. , 2006, Science.

[51]  M. Hung,et al.  b-Catenin , a novel prognostic marker for breast cancer : Its roles in cyclin D 1 expression and cancer progression , 2000 .